Clinical Trial Update: A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the completed Phase 1 and Phase 2 study of AK104 in patients with locally advanced or metastatic non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AK104 (PD-1/CTLA-4 bispecific antibody)

Snippet

Sponsor: Akeso | Conditions: Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV | Phase 1, Phase 2 | Status: COMPLETED